Gd‐DOTA as a gastrointestinal contrast agent for gastric emptying measurements with MRI

Current MR meal markers may interfere with gastric motility and secretion restricting the use of MRI in the measurement of gastric physiology. We therefore evaluated Gd‐DOTA as a liquid phase marker, in vitro by determining dissociation, and adherence to the solids, and in vivo by simultaneous MRI (0.35 T scanner, multiple T1‐weighted sections of the upper abdomen) and double indicator (perfusion marker PEG 4000, meal marker 99mTc‐DTPA) measurements of emptying and secretion, following ingestion of 500 ml 10% glucose. In vitro Gd‐DOTA was stable at a pH > 2 with < 2% dissociation at 24 h during incubation with HCI. Dissociation during incubation with HCI was linearly dependent on H+ concentration (0.77 < pH < 2.02). Less Gd‐DOTA was absorbed onto the solid phase than 99mTc‐DTPA (25% cf 36%). in vivo Gd‐DOTA marked gastric contents provided strong positive contrast. Similar emptying curves were observed with both MRI and double‐indicator techniques (r = 0.987, P < 0.001). Gd‐DOTA has the potential to be a useful liquid phase contrast agent in MR studies on gastric function.

[1]  W. Schwizer,et al.  Measurement of gastric emptying by magnetic resonance imaging in humans. , 1992, Gastroenterology.

[2]  R. Brasch New directions in the development of MR imaging contrast media. , 1992, Radiology.

[3]  J. Heiken,et al.  Perfluoroctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon. , 1991, Radiology.

[4]  C. Claussen,et al.  Gadopentetate dimeglumine as a bowel contrast agent: safety and efficacy. , 1991, Radiology.

[5]  K. C. Li,et al.  Enteric MRI contrast agents: comparative study of five potential agents in humans. , 1991, Magnetic resonance imaging.

[6]  E M Haacke,et al.  Fast MR imaging: techniques and clinical applications. , 1990, AJR. American journal of roentgenology.

[7]  P. Niemi,et al.  Superparamagnetic Particles as Gastrointestinal Contrast Agent in Magnetic Resonance Imaging of Lower Abdomen , 1990, Acta radiologica.

[8]  R Weissleder,et al.  First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. , 1990, Radiology.

[9]  A. Ericsson,et al.  Effect of Superparamagnetic Particles as Oral Contrast Medium at Magnetic Resonance Imaging , 1989, Acta radiologica.

[10]  R. Felix,et al.  MR imaging of the gastrointestinal tract: value of Gd-DTPA. , 1988, AJR. American journal of roentgenology.

[11]  J. Wittenberg,et al.  Gd-DOTA: characterization of a new paramagnetic complex. , 1988, Radiology.

[12]  M. Brechbiel,et al.  Gd(DOTA): An alternative to Gd(DTPA) as a T1,2 relaxation agent for NMR imaging or spectroscopy , 1986, Magnetic resonance in medicine.

[13]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[14]  J. Weinreb,et al.  Improved MR Imaging of the Upper Abdomen with Glucagon and Gas , 1984, Journal of computer assisted tomography.

[15]  L. Crooks,et al.  Nuclear magnetic resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions. , 1983, Radiology.

[16]  Fordtran Js Marker perfusion techniques for measuring intestinal absorption in man. , 1966 .

[17]  T. Haley,et al.  Pharmacology and toxicology of the rare earth elements. , 1965, Journal of pharmaceutical sciences.